Sun, C., Lu, B., Liu, Y., Zhang, Y., Wei, H., Hu, X., . . . Cheng, R. (2021). Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A.
Chicago Style (17th ed.) CitationSun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationSun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.